Head-to-head · WeighScore
9amHealth vs Ageless
The verdict
Ageless takes it — 84.8/100 to 71.3/100.
Ageless grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the broadest compounded storefronts on the board — GLP-1, NAD+, sermorelin, TRT and more under one roof, in both injectable and oral routes, on low headline pricing (semaglutide $119/mo, tirzepatide $169/mo) — offset by a compounded-only catalog and an undisclosed state list.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | 9amHealth | Ageless |
|---|---|---|
| WeighScore | 71.3/100 | 84.8/100 |
| Grade | C | B |
| Scorecard rank | #93 | #10 |
| Semaglutide | $149/mo (plus a separate fee, brand-name) | $119/mo |
| Tirzepatide | Not disclosed | $169/mo |
| Coverage | Coverage not published | Varies by state |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #93 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
- $149/month membership or free when covered by insurance
- Membership includes specialists, labs, devices, and medications
- Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
- Helps navigate insurance approvals; employer and state-plan partnerships
Where it loses points
- Medication coverage and GLP-1 access depend on insurance and BMI criteria
- State availability not enumerated on the public site
- Branded GLP-1s can be costly without insurance coverage
- Pricing for medications not transparently listed
Graded #10 · B
Strengths
- Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
- Low headline GLP-1 pricing — semaglutide $119/mo, tirzepatide $169/mo — no insurance, with Klarna/Affirm financing
- Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures
- Oral routes available (drops and troches), not injection-only
Where it loses points
- Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
- Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
- No published state-availability list and no named legal entity or medical group
- Thin public track record, and advertised prices are floors set after clinical review
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.